CStone Pharmaceuticals
Headquarters country
China
Registry sponsor category
Industry
- Other names
- CStone Pharmaceuticals
- Company name
- CStone Pharmaceuticals
- Organisation type
- Industry
- Registered legal name
- CSTONE PHARMACEUTICALS
- Registry sponsor category
- Industry
- Legal Entity Identifier (LEI)
- 300300095A57F80T2461
Related records
Trials (29)
- A China Bridging Study of Ivosidenib in r/r AML Subjects With an IDH1 Mutation
- A Phase I Study of CS1002 in Subjects With Advanced Solid Tumors
- A Phase I Study of CS5007 in Participants With Advanced Solid Tumors
- A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
- A Phase Ia/Ib Study of CS1001 in Subjects With Advanced Solid Tumors
- A Phase Ib/II Study of Fisogatinib(BLU-554) in Subjects With Hepatocellular Carcinoma
- A Study of CS1001 in Combination With Donafenib in Subjects With Advanced Solid Tumors
- A Study of CS1001 in Combination With Regorafenib in Patients With Advanced or Refractory Solid Tumors
- A Study of CS1001 in Subjects with Advanced Solid Tumors
- A Study of CS1001 in Subjects With Esophageal Squamous Cell Carcinoma
- A Study of CS1001 in Subjects With Gastric Adenocarcinoma or Gastro-Esophageal Junction Adenocarcinoma
- A Study of CS1001 in Subjects With Relapsed or Refractory Classical Hodgkin Lymphoma
- A Study of CS1001 in Subjects With Relapsed or Refractory Extranodal Natural Killer/ T Cell Lymphoma(ENKTL)
- A Study of CS1001 in Subjects With Stage III Non-Small Cell Lung Cancer
- A Study of CS1001 in Subjects With Stage IV Non-Small Cell Lung Cancer
- A Study of CS1002 in Subjects with Advanced Solid Tumors
- A Study of CS1003 in Subjects With Advanced Solid Tumors
- A Study of CS1003 in Subjects With Advanced Solid Tumors or Lymphomas
- A Study of CS3002 in Subjects With Advanced Solid Tumors
- A Study of CS3005 in Advanced Solid Tumors